Home Biosciences Altera is led by a team of scientists and entrepreneurs with experience spanning cell therapy, gene regulation, and early stage biotech. together, we bring a shared commitment to advancing science that’s accessible, globally relevant, and built for real world impact. New vantage points new insights life science discovery altera bio (c) mmxxii.
Home Biosciences Generating Life Changing Medicines For Patients Altera biosciences is a preclinical stage biotechnology company developing a universal donor cell platform to power the next generation of off the shelf allogeneic cell therapies. Altera has the story, the team, and the initial cash. now, it faces the unenviable task of turning a brilliant concept into a biological reality. the global biotech community will be watching to see if africa’s first gene therapy gambit pays off. Cape town based biotech startup altera biosciences has secured r29 million (about $1.6 million) in pre seed funding to develop gene edited cells that can be used in any patient, regardless of biological match. Information on valuation, funding, cap tables, investors, and executives for altera biosciences. use the pitchbook platform to explore the full profile.
Altera Biosciences Financial Details Cape town based biotech startup altera biosciences has secured r29 million (about $1.6 million) in pre seed funding to develop gene edited cells that can be used in any patient, regardless of biological match. Information on valuation, funding, cap tables, investors, and executives for altera biosciences. use the pitchbook platform to explore the full profile. Altera biosciences, positioning itself as africa’s first dedicated cell and gene therapy startup, has raised r29 million (approximately $1.6 million) in a pre seed funding round to pursue one of biotechnology’s most ambitious goals: the creation of universal donor cells. Altera biosciences has raised $1.6m in pre seed funding to develop universal donor cell therapies that bypass immune rejection. led by alexandra miszewski, the cape town based startup is africa’s first venture dedicated to cell and gene therapy. Find company research, competitor information, contact details & financial data for altera biosciences inc. of greenville, de. get the latest business insights from dun & bradstreet. In a historic leap for biotech in africa, pretoria based altera biosciences has secured r29 million in pre seed funding to develop a universal donor cell platform aimed at revolutionising transplant medicine.
Home Altera Altera biosciences, positioning itself as africa’s first dedicated cell and gene therapy startup, has raised r29 million (approximately $1.6 million) in a pre seed funding round to pursue one of biotechnology’s most ambitious goals: the creation of universal donor cells. Altera biosciences has raised $1.6m in pre seed funding to develop universal donor cell therapies that bypass immune rejection. led by alexandra miszewski, the cape town based startup is africa’s first venture dedicated to cell and gene therapy. Find company research, competitor information, contact details & financial data for altera biosciences inc. of greenville, de. get the latest business insights from dun & bradstreet. In a historic leap for biotech in africa, pretoria based altera biosciences has secured r29 million in pre seed funding to develop a universal donor cell platform aimed at revolutionising transplant medicine.
Home Altera Find company research, competitor information, contact details & financial data for altera biosciences inc. of greenville, de. get the latest business insights from dun & bradstreet. In a historic leap for biotech in africa, pretoria based altera biosciences has secured r29 million in pre seed funding to develop a universal donor cell platform aimed at revolutionising transplant medicine.
Comments are closed.